Francisco González Bobes | CPhI North America

CPhI North America is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

 

View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.

Francisco González BobesSenior Principal ScientistBristol-Myers Squibb

Francisco González Bobes was born and raised in Oviedo, Spain. He completed his undergraduate
studies at Universidad de Oviedo (Spain) in 1994 majoring both in Organic and Analytical
Chemistry. Francisco pursued doctoral studies at Instituto Universitario de Química
Organometálica (Universidad de Oviedo) obtaining his Ph.D. in 2003 under the guidance of
Professors José Barluenga and José Manuel González. His work focused on studying oxidation,
C-H functionalization, and C-C bond fragmentation reactions mediated by iodine-containing
reagents. In 2004, Francisco joined the laboratory of Professor Greg Fu at the Massachusetts
Institute of Technology as a Merck postdoctoral fellow. At MIT, he discovered that amino
alcohols and diamines could be used as ligands in asymmetric nickel-catalyzed cross-coupling
reactions of alkyl electrophiles bearing beta-hydrogens.

Francisco joined Bristol-Myers Squibb (BMS) in 2006 as a member of the Process Research &
Development department in New Brunswick, New Jersey (now Chemical & Synthetic
Development-CSD). Since then, he has applied his passion for chemistry to deliver innovative
solutions in the development of over 20 pharmaceutical candidates in areas such as immunooncology,
cardiovascular disease, immunoscience, central nervous system, and virology.
Currently, Francisco leads several projects in the BMS development portfolio, and is a technical
leader for CSD's interactions with several Chemical Research and Manufacturing Organizations.

Presenting: